T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
RingCentral
RNG
$5.32B
| $52.2M | 0.01% |
3,402,321
+41,147
| +1% | +$620K |
|
|
CERN
827
DELISTED
Cerner Corp
CERN
| $52.1M | 0.01% |
711,390
+8,005
| +1% | +$554K |
|
|
KS
828
DELISTED
KapStone Paper and Pack Corp.
KS
| $51.9M | 0.01% |
1,581,240
-64,300
| -4% | -$2.05M |
|
829
National Healthcare
NHC
$3.48B
| $51.9M | 0.01% |
814,697
-8,220
| -1% | -$522K |
|
830
Diodes
DIOD
$4.58B
| $51.8M | 0.01% |
1,814,332
-71,820
| -4% | -$2.01M |
|
|
OREX
831
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $51.8M | 0.01% |
661,280
-5,240
| -0.8% | -$325K |
|
|
MJN
832
DELISTED
Mead Johnson Nutrition Company
MJN
| $51.6M | 0.01% |
513,767
+44,395
| +9% | +$4.48M |
|
833
Eversource Energy
ES
$27.1B
| $51.6M | 0.01% |
1,020,698
-214,706
| -17% | -$11.3M |
|
834
Skyworks Solutions
SWKS
$10.5B
| $51.5M | 0.01% |
524,309
+244,721
| +88% | +$20.9M |
|
835
International Flavors & Fragrances
IFF
$21.4B
| $51.2M | 0.01% |
436,377
-54,200
| -11% | -$6.12M |
|
836
Quanta Services
PWR
$102B
| $51M | 0.01% |
1,786,681
-2,553,680
| -59% | -$71.6M |
|
837
Myers Industries
MYE
$1.27B
| $51M | 0.01% |
2,906,655
-36,620
| -1% | -$646K |
|
|
GTLS
838
DELISTED
Chart Industries
GTLS
| $50.8M | 0.01% |
1,449,640
+14,052
| +1% | +$452K |
|
839
Cheesecake Factory
CAKE
$5.7B
| $50.7M | 0.01% |
1,027,080
-24,913
| -2% | -$1.26M |
|
840
Sunstone Hotel Investors
SHO
$2.03B
| $50.5M | 0.01% |
3,030,374
+2,983,200
| +6,324% | +$51.2M |
|
841
Kite Realty
KRG
$5.3B
| $50.2M | 0.01% |
1,782,469
-89,740
| -5% | -$2.6M |
|
|
EXPR
842
DELISTED
Express, Inc.
EXPR
| $50.1M | 0.01% |
151,522
+976
| +0.6% | +$282K |
|
843
Abercrombie & Fitch
ANF
$4.84B
| $49.8M | 0.01% |
2,260,400
+1,189,630
| +111% | +$29.3M |
|
|
IRBT
844
DELISTED
iRobot
IRBT
| $49.4M | 0.01% |
1,514,300
-154,700
| -9% | -$5.02M |
|
845
Autoliv
ALV
$8.85B
| $49.4M | 0.01% |
578,267
-84,944
| -13% | -$6.73M |
|
|
TLMR
846
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $49.4M | 0.01% |
3,223,570
+155,350
| +5% | +$2.19M |
|
|
BRS
847
DELISTED
Bristow Group, Inc.
BRS
| $49.2M | 0.01% |
903,515
+127,280
| +16% | +$7.53M |
|
|
RLD
848
DELISTED
REALD INC COM STK
RLD
| $49.2M | 0.01% |
3,844,600
-33,000
| -0.9% | -$396K |
|
|
VIVO
849
DELISTED
Meridian Bioscience Inc
VIVO
| $49.1M | 0.01% |
2,571,445
-100,560
| -4% | -$1.86M |
|
850
Methode Electronics
MEI
$604M
| $49M | 0.01% |
1,042,590
-197,780
| -16% | -$7.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.